These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 33471243)

  • 1. Harm Reduction and Adaptations Among PWUD in Rural Oregon During COVID-19.
    Seaman A; Leichtling G; Stack E; Gray M; Pope J; Larsen JE; Leahy JM; Gelberg L; Korthuis PT
    AIDS Behav; 2021 May; 25(5):1331-1339. PubMed ID: 33471243
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Program Adaptations to Provide Harm Reduction Services During the COVID-19 Pandemic: A Qualitative Study of Syringe Services Programs in the U.S.
    Frost MC; Sweek EW; Austin EJ; Corcorran MA; Juarez AM; Frank ND; Prohaska SM; LaKosky PA; Asher AK; Broz D; Jarlais DCD; Williams EC; Glick SN
    AIDS Behav; 2022 Jan; 26(1):57-68. PubMed ID: 34110506
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barriers to engaging people who use drugs in harm reduction services during the COVID-19 pandemic: A mixed methods study of syringe services program perspectives.
    Austin EJ; Corcorran MA; Briggs ES; Frost MC; Behrends CN; Juarez AM; Frank ND; Healy E; Prohaska SM; LaKosky PA; Kapadia SN; Perlman DC; Schackman BR; Jarlais DCD; Williams EC; Glick SN
    Int J Drug Policy; 2022 Nov; 109():103825. PubMed ID: 35977459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of the COVID-19 pandemic on people who inject drugs accessing harm reduction services in an rural American state.
    Thakarar K; Kohut M; Hutchinson R; Bell R; Loeb HE; Burris D; Fairfield KM
    Harm Reduct J; 2022 Jul; 19(1):80. PubMed ID: 35869523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the impact of the COVID-19 pandemic on syringe services programs in rural Kentucky.
    Glick JL; Grieb SM; Harris SJ; Weir BW; Smith KC; Puryear T; Hamilton White R; Allen ST
    Harm Reduct J; 2022 May; 19(1):47. PubMed ID: 35590373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of COVID-19 on access to harm reduction, substance use treatment and recovery services in Scotland: a qualitative study.
    Schofield J; Dumbrell J; Matheson C; Parkes T; Bancroft A
    BMC Public Health; 2022 Mar; 22(1):500. PubMed ID: 35287630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attitudes toward harm reduction and low-threshold healthcare during the COVID-19 pandemic: qualitative interviews with people who use drugs in rural southern Illinois.
    Rains A; York M; Bolinski R; Ezell J; Ouellet LJ; Jenkins WD; Pho MT
    Harm Reduct J; 2022 Nov; 19(1):128. PubMed ID: 36403075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Harm reduction via online platforms for people who use drugs in Russia: a qualitative analysis of web outreach work.
    Davitadze A; Meylakhs P; Lakhov A; King EJ
    Harm Reduct J; 2020 Dec; 17(1):98. PubMed ID: 33298081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identifying the impacts of the COVID-19 pandemic on service access for people who use drugs (PWUD): A national qualitative study.
    Russell C; Ali F; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    J Subst Abuse Treat; 2021 Oct; 129():108374. PubMed ID: 34080545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020.
    Behrends CN; Lu X; Corry GJ; LaKosky P; Prohaska SM; Glick SN; Kapadia SN; Perlman DC; Schackman BR; Des Jarlais DC
    Drug Alcohol Depend; 2022 Mar; 232():109323. PubMed ID: 35124386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Law enforcement and syringe services program implementation in rural counties in Kentucky: a qualitative exploration.
    Allen ST; Danforth S; Grieb SM; Glick JL; Harris SJ; Tomko C; Sherman SG
    Harm Reduct J; 2022 Sep; 19(1):109. PubMed ID: 36180853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Examining risk behavior and syringe coverage among people who inject drugs accessing a syringe services program: A latent class analysis.
    Bartholomew TS; Tookes HE; Bullock C; Onugha J; Forrest DW; Feaster DJ
    Int J Drug Policy; 2020 Apr; 78():102716. PubMed ID: 32146348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intersecting substance use treatment and harm reduction services: exploring the characteristics and service needs of a community-based sample of people who use drugs.
    Krawczyk N; Allen ST; Schneider KE; Solomon K; Shah H; Morris M; Harris SJ; Sherman SG; Saloner B
    Harm Reduct J; 2022 Aug; 19(1):95. PubMed ID: 36002850
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward a human-centered use of technology: a stakeholder analysis of harm reduction and CBO staff.
    Aronson ID; Bennett AS; Freeman R
    Harm Reduct J; 2020 Oct; 17(1):77. PubMed ID: 33076911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preliminary indications of the burden of COVID-19 among people who inject drugs in England and Northern Ireland and the impact on access to health and harm reduction services.
    Croxford S; Emanuel E; Ibitoye A; Njoroge J; Edmundson C; Bardsley M; Heinsbroek E; Hope V; Phipps E
    Public Health; 2021 Mar; 192():8-11. PubMed ID: 33601307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic.
    Lindqvist K; Wallmofeldt C; Holmén E; Hammarberg A; Kåberg M
    Harm Reduct J; 2021 May; 18(1):52. PubMed ID: 33971892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Community Perceptions of Comprehensive Harm Reduction Programs and Stigma Towards People Who Inject Drugs in Rural Virginia.
    Baker LS; Smith W; Gulley T; Tomann MM
    J Community Health; 2020 Apr; 45(2):239-244. PubMed ID: 31502098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Motivation to Change and Treatment Participation Among Syringe Service Program Utilizers in Rural Kentucky.
    Surratt HL; Otachi JK; Williams T; Gulley J; Lockard AS; Rains R
    J Rural Health; 2020 Mar; 36(2):224-233. PubMed ID: 31415716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rural risk environments for hepatitis c among young adults in appalachian kentucky.
    Cloud DH; Ibragimov U; Prood N; Young AM; Cooper HLF
    Int J Drug Policy; 2019 Oct; 72():47-54. PubMed ID: 31113713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Syringe Services Programs' Role in Ending the HIV Epidemic in the U.S.: Why We Cannot Do It Without Them.
    Broz D; Carnes N; Chapin-Bardales J; Des Jarlais DC; Handanagic S; Jones CM; McClung RP; Asher AK
    Am J Prev Med; 2021 Nov; 61(5 Suppl 1):S118-S129. PubMed ID: 34686281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.